Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6512-6522

  Hasan, Lara ^a   Mazzucchelli, Luca ^a,c   Liebi, Mark ^b   Maddalena Lis, ^a   Hunger, Robert E ^a   Tester, Angus ^b,d   Overall, Christopher M ^b,d   Wolf, Marlene ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Istituto di Patologia   (Switzerland)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CALCIUM ION; CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; CCL20 CHEMOKINE; CHEMOKINE; DNA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIGAND; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; CALCIUM MOBILIZATION; CASE REPORT; CELL MIGRATION; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN SITU HYBRIDIZATION; LEUKOCYTE FUNCTION; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS;

EID: 33646857762     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6512     Document Type: Article

References (59)

1. Moser, B., M. Wolf, A. Walz, and P. Loetscher. 2004. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 25: 75-84.
2. Thelen, M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2: 129-134.
3. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
4. Balkwill, F. 2004. Cancer and the chemokine network. Nat. Rev. Cancer 4: 540-550.
5. Yang, D., Q. Chen, D. M. Hoover, P. Staley, K. D. Tucker, J. Lubkowski, and J. J. Oppenheim. 2003. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J. Leukocyte Biol. 74: 448-455.
6. Delgado, M. B., I. Clark-Lewis, P. Loetscher, H. Langen, M. Thelen, M. Baggiolini, and M. Wolf. 2001. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur. J. Immunol. 31: 699-707.
7. Wolf, M., I. Clark-Lewis, C. Buri, H. Langen, M. Lis, and L. Mazzucchelli. 2003. Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1α, macrophage inflammatory protein-1β, and SLC that are expressed in human breast cancer. Am. J. Pathol. 162: 1183-1190.
8. Nufer, O., M. Corbett, and A. Walz. 1999. Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 38: 636-642.
9. Padrines, M., M. Wolf, A. Walz, and M. Baggiolini. 1994. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352: 231-235.
10. Ohashi, K., M. Naruto, T. Nakaki, and E. Sano. 2003. Identification of interleukin-8 converting enzyme as cathepsin L. Biochim. Biophys. Acta 1649: 30-39.
11. Car, B. D., M. Baggiolini, and A. Walz. 1991. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue- activating peptide III by different tissue proteinases. Biochem. J. 275: 581-584.
12. Balbin, M., A. Fueyo, A. M. Tester, A. M. Pendas, A. S. Pitiot, A. Astudillo, C. M. Overall, S. D. Shapiro, and C. Lopez-Otin. 2003. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35: 252-257.
13. McQuibban, G. A., G. S. Butler, J. H. Gong, L. Bendall, C. Power, I. Clark-Lewis, and C. M. Overall. 2001. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276: 43503-43508.
14. Zhang, K., G. A. McQuibban, C. Silva, G. S. Butler, J. B. Johnston, J. Holden, I. Clark-Lewis, C. M. Overall, and C. Power. 2003. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6: 1064-1071.
15. McQuibban, G. A., J. H. Gong, E. M. Tam, C. A. McCulloch, I. Clark-Lewis, and C. M. Overall. 2000. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202-1206.
16. Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
17. Westley, B. R., and F. E. May. 1996. Cathepsin D and breast cancer. Eur. J. Cancer 32A: 15-24.
18. r 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res. 49: 6008-6014.
19. Otto, F. J., T. Goldmann, B. Biess, A. Lippold, L. Suter, and U. Westhoff. 1999. Prognostic classification of malignant melanomas by combining clinical, histological, and immunohistochemical parameters. Oncology 56: 208-214.
20. Hieshima, K., T. Imai, G. Opdenakker, J. Van Damme, J. Kusuda, H. Tei, Y. Sakaki, K. Takatsuki, R. Miura, O. Yoshie, and H. Nomiyama. 1997. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver: chemotactic activity for lymphocytes and gene localization on chromosome 2. J. Biol. Chem. 272: 5846-5853.
21. Charbonnier, A. S., N. Kohrgruber, E. Kriehuber, G. Stingl, A. Rot, and D. Maurer. 1999. Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 190: 1755-1768.
22. Tanaka, Y., T. Imai, M. Baba, I. Ishikawa, M. Uehira, H. Nomiyama, and O. Yoshie. 1999. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29: 633-642.
23. Iwasaki, A., and B. L. Kelsall. 2000. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J. Exp. Med. 191: 1381-1394.
24. Cook, D. N., D. M. Prosser, R. Forster, J. Zhang, N. A. Kuklin, S. J. Abbondanzo, X. D. Niu, S. C. Chen, D. J. Manfra, M. T. Wiekowski, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12: 495-503.
25. Power, C. A., D. J. Church, A. Meyer, S. Alouani, A. E. Proudfoot, I. Clark-Lewis, S. Sozzani, A. Mantovani, and T. N. Wells. 1997. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3α from lung dendritic cells. J. Exp. Med. 186: 825-835.
26. Liao, F., R. Alderson, J. Su, S. J. Ullrich, B. L. Kreider, and J. M. Farber. 1997. STRL22 is a receptor for the CC chemokine MIP-3α. Biochem. Biophys. Res. Commun. 236: 212-217.
27. Al-Aoukaty, A., B. Rolstad, A. Giaid, and A. A. Maghazachi. 1998. MIP-3α, MIP-3β and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells. Immunology 95: 618-624.
28. Campbell, J. J., J. Hedrick, A. Zlotnik, M. A. Siani, D. A. Thompson, and E. C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279: 381-384.
29. Dieu, M. C., B. Vanbervliet, A. Vicari, J. M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, and C. Caux. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188: 373-386.
30. Liao, F., R. L. Rabin, C. S. Smith, G. Sharma, T. B. Nutman, and J. M. Farber. 1999. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J. Immunol. 162: 186-194.
31. Liao, F., A. K. Shirakawa, J. F. Foley, R. L. Rabin, and J. M. Farber. 2002. Human B cells become highly responsive to macrophage-inflammatory protein-3α/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J. Immunol. 168: 4871-4880.
32. Rossi, D. L., A. P. Vicari, K. Franz-Bacon, T. K. McClanahan, and A. Zlotnik. 1997. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3α and MIP-3β. J. immunol. 158: 1033-1036.
33. Kimura, T., H. Takeshima, N. Nomiyama, T. Nishi, T. Kino, M. Kochi, J. I. Kuratsu, and Y. Ushio. 2002. Expression of lymphocyte-specific chemokines in human malignant glioma: essential role of LARC in cellular immunity of malignant glioma. Int. J. Oncol. 21: 707-715.
34. Clark-Lewis, I., L. Vo, P. Owen, and J. Anderson. 1997. Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. Methods Enzymol. 287: 233-250.
35. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T lymphocytes. J. Exp. Med. 184: 963-969.
36. von Tscharner, V., B. Prod'hom, M. Baggiolini, and H. Reuter. 1986. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature 324: 369-372.
37. Heylen, N., L. M. Vincent, V. Devos, V. Dubois, C. Remade, and A. Trauet. 2002. Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process. Int. J. Oncol. 20: 761-767.
38. Guo, M., P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners, Jr. 2002. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-βL a process initiated by the exocytosis of cathepsin B. J. Biol. Chem. 277: 14829-14837.
39. Schaerli, P., K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553-1562.
40. Hoover, D. M., C. Boulegue, D. Yang, J. J. Oppenheim, K. Tucker, W. Lu, and J. Lubkowski. 2002. The structure of human macrophage inflammatory protein-3α/CCL20: linking antimicrobial and CC chemokine receptor-6-binding activities with human β-defensins. J. Biol. Chem. 277: 37647-37654.
41. Schmuth, M., S. Neyer, C. Rainer, A. Grassegger, P. Fritsch, N. Romani, and C. Heufler. 2002. Expression of the C-C chemokine MIP-3α/CCL20 in human epidermis with impaired permeability barrier function. Exp. Dermatol. 11: 135-142.
42. Homey, B., H. Alenius, A. Muller, H. Soto, E. P. Bowman, W. Yuan, L. McEvoy, A. I. Lauerma, T. Assmann, E. Bunemann, et al. 2002. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8: 157-165.
43. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38: 12959-12968.
44. Culley, F. J., E. J. Fadlon, A. Kirchem, T. J. Williams, P. J. Jose, and J. E. Pease. 2003. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur. J. Immunol. 33: 1302-1310.
45. Bruhl, H., C. D. Cohen, S. Linder, M. Kretzler, D. Schlondorff, and M. Mack. 2003. Post-translational and cell type-specific regulation of CXCR4 expression by cytokines. Eur. J. Immunol. 33: 3028-3037.
46. Lah, T. T., M. Cercek, A. Blejec, J. Kos, E. Gorodetsky, R. Somers, and I. Daskal. 2000. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin. Cancer Res. 6: 578-584.
47. Kos, J., B. Werle, T. Lah, and N. Brunner. 2000. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int. J. Biol. Markers 15: 84-89.
48. Ehlert, J. E., F. Petersen, M. H. Kubbutat, J. Gerdes, H. D. Flad, and E. Brandt. 1995. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2): comparison of native and recombinant NAP-2 variants. J. Biol. Chem. 270: 6338-6344.
49. Ehlert, J. E., J. Gerdes, H. D. Flad, and E. Brandt. 1998. Novel C-terminally truncated isoforms of the CXC chemokine β-thromboglobulin and their impact on neutrophil functions. J. Immunol. 161: 4975-4982.
50. Hensbergen, P. J., D. Verzijl, C. I. Balog, R. Dijkman, R. C. van der Schors, E. M. van der Raaij-Helmer, M. J. van der Plas, R. Leurs, A. M. Deelder, M. J. Smit, and C. P. Tensen. 2004. Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity. J. Biol. Chem. 279: 13402-13411.
51. Schutyser, E., S. Struyf, P. Menten, J. P. Lenaerts, R. Conings, W. Put, A. Wuyts, P. Proost, and J. Van Damme. 2000. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3α from normal and transformed cells. J. Immunol. 165: 4470-4477.
52. Tannock, I. F., and D. Rotin. 1989. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49: 4373-4384.
53. Polgar, L., and C. Csoma. 1987. Dissociation of ionizing groups in the binding cleft inversely controls the endo- and exopeptidase activities of cathepsin B. J. Biol. Chem. 262: 14448-14453.
54. Sadir, R., A. Imberty, F. Baleux, and H. Lortat-Jacob. 2004. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J. Biol. Chem. 279: 43854-43860.
55. Webb, L. M., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90: 7158-7162.
56. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36: 13570-13578.
57. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361: 79-82.
58. Tanaka, Y., K. Kimata, A. Wake, S. Mine, I. Morimoto, N. Yamakawa, H. Habuchi, S. Ashikari, H. Yamamoto, K. Sakurai, et al. 1996. Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J. Exp. Med. 184: 1987-1997.
59. J. Exp. Med. Vol. 176 No. 11